Poland - Vaccines

Description

The subject of the contract is the supply of COMPOUNDED VIACEPTURE AGAINST: DIAGNOSIS, TETANUS, CRZTOSCOW (FREE, COMPOUNDED), POLYOMYELITIS (INACTIVATED) AND HEAMOPHILIS INFLUENZAE TYPE B - INJ. 0.5 ML; INFANRIX-IPV+HIBIn accordance with the description of the subject of the contract specified in the SWZ and under the conditions specified in the draft provisions of the contract, which are attached to the SWZ.
1. combination vaccine against: diphtheria, tetanus, pertussis (cell-free, combination), poliomyelitis (inactivated) and heamophilus influenzae type B - inj. 0.5 ml; Infanrix-IPV+Hib in the number of 2,600 doses2. Evidence in question:2.1. Pursuant to Article 105 and Article 106 of the PPL Act. in order to confirm the compliance of the offered supplies with the requirements, features or criteria specified in the description of the subject matter of the contract or the criteria for evaluation of tenders or the requirements related to the execution of the contract, the contracting authority shall require the contractors to present:A valid, current marketing authorization for a medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,orA valid, current marketing authorization for a medicinal product issued by the Council of the European Union or the European Commission,2..2 Pursuant to Article 107(1) of the PPL Act, the Contractor shall submit the above-mentioned means of evidence together with the bid, and the Contractor shall exercise all due diligence to ensure that these documents are complete and contain all necessary information to enable the Contracting Authority to verify their accuracy.2..3. . The Contractor shall be obliged to inform the Contracting Authority of the transfer to another entity of the rights and obligations of the responsible entity under the Marketing Authorization for the medicinal product.2 .4. The Marketing Authorization for the medicinal product must be valid and current as of the date of submission of bids.2..5. the composition of the preparation and packaging must be in accordance with the content of the documents referred to in paragraph 2.1.2.6. in the event that the validity of the document expires, the Contractor shall provide the Purchaser with the documents referred to in paragraph 2.1. an additional document declaring the timely submission of an application for renewal of the marketing authorization for the medicinal product or, if obtained, a valid marketing authorization for the medicinal product.2..7 The aforementioned documents must have a validity period covering the entire period of performance of the contract.2.8 The documents referred to above shall be submitted in the manner provided for in the regulations issued pursuant to Article 70 of the PPL Act.2.9 The Contracting Authority, pursuant to Article 107(2) of the PPL Act, provides for the possibility of supplementing the aforementioned means of proof once within the time limit set by the Contracting Authority.2.10 Documents prepared in a foreign language shall be submitted together with a translation into Polish.

Opportunity closing date

16 August 2022

Value of contract

to be confirmed